CAMBELL INTERNATIONAL HOLDING CORP.

Medicinal Chemicals & Botanical Products·BANGKOK, W1

Summary Financials

Revenue

$463,076

-44.2% YoY

FY 2024

Adj. EBITDA

-$1.1M

-240.2% margin

FY 2024

Net Income

-$1.1M

-236.7% margin

FY 2024

EPS (Diluted)

-$0.15

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$286,272

FY 2024

Total Debt

—

Net Cash

$286,272

FY 2024

Enterprise Value

—

Debt / EBITDA

0.3x

FY 2024

EV / EBITDA

—

Employees

—

Revenue

$463,076

-44.2% YoY

FY 2024

Adj. EBITDA

-$1.1M

-240.2% margin

FY 2024

Net Income

-$1.1M

-236.7% margin

FY 2024

EPS (Diluted)

-$0.15

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$286,272

FY 2024

Total Debt

—

Net Cash

$286,272

FY 2024

Enterprise Value

—

Debt / EBITDA

0.3x

FY 2024

EV / EBITDA

—

Employees

—